Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax | Zendy

Michael S. Seaman | Zendy; Marissa B. Wilck | Zendy; Lindsey R. Baden | Zendy; Stephen R. Walsh | Zendy; Lauren E. Grandpre | Zendy; Colleen Devoy | Zendy; Ayush Giri | Zendy; Lizanne C. Noble | Zendy; Jane A. Kleinjan | Zendy; Kristen E. Stevenson | Zendy; Haesook T. Kim | Zendy; Raphael Dolin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax

Author(s) -

Michael S. Seaman,

Marissa B. Wilck,

Lindsey R. Baden,

Stephen R. Walsh,

Lauren E. Grandpre,

Colleen Devoy,

Ayush Giri,

Lizanne C. Noble,

Jane A. Kleinjan,

Kristen E. Stevenson,

Haesook T. Kim,

Raphael Dolin

Publication year - 2010

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/651560

Subject(s) - vaccinia , modified vaccinia ankara , titer , medicine , smallpox vaccine , virology , vaccination , smallpox , immunization , virus , immunology , neutralizing antibody , antibody , biology , biochemistry , gene , recombinant dna

Despite the success of smallpox vaccination, the immunological correlates of protection are not fully understood. To investigate this question, we examined the effect of immunization with modified vaccinia Ankara (MVA) on subsequent challenge with replication-competent vaccinia virus (Dryvax).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research